• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于气液界面条件下病毒感染研究的生物打印四细胞类型肺模型

Bioprinted Four-Cell-Type Lung Model for Viral Infection Studies Under Air-Liquid Interface Conditions.

作者信息

Berg Johanna, Heinze Julian, Niemeyer Daniela, Hellgren Josefin, Jaiswal Himjyot, Löwa Anna, Hocke Andreas, Namro Itedale, Drosten Christian, Kurreck Jens, Tolksdorf Beatrice

机构信息

Department of Applied Biochemistry, Institute of Biotechnology, Technische Universität Berlin, 10623 Berlin, Germany.

German Center for Infection Research (DZIF), Charitéplatz 1, 10117 Berlin, Germany.

出版信息

Int J Mol Sci. 2025 Jun 10;26(12):5543. doi: 10.3390/ijms26125543.

DOI:10.3390/ijms26125543
PMID:40565011
Abstract

Viral lung infections are a never-ending threat to public health due to the emergence of new variants and their seasonal nature. While vaccines offer some protection, the need for effective antiviral drugs remains high. The existing research methods using 2D cell culture and animal models have their limitations. Human cell-based tissue engineering approaches hold great promise for bridging this gap. Here, we describe a microextrusion bioprinting approach to generate three-dimensional (3D) lung models composed of four cell types: endothelial cells, primary fibroblasts, macrophage cells, and epithelial cells. A549 and Calu-3 cells were selected as epithelial cells to simulate the cells of the lower and upper respiratory tract, respectively. Cells were bioprinted in a hydrogel consisting of alginate, gelatin, hyaluronic acid, collagen, and laminin-521. The models were cultured under air-liquid interface (ALI) conditions to further enhance their physiological relevance as lung cells. Their viability, metabolic activity, and expression of specific cell markers were analyzed during long-term culture for 21 days. The constructs were successfully infected with both a seasonal influenza A virus (IAV) and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron variant, demonstrating their potential for studying diverse viral infections.

摘要

由于新变种的出现及其季节性特征,病毒性肺部感染对公众健康构成了持续不断的威胁。虽然疫苗提供了一定程度的保护,但对有效抗病毒药物的需求仍然很高。现有的使用二维细胞培养和动物模型的研究方法存在局限性。基于人类细胞的组织工程方法在弥合这一差距方面具有巨大潜力。在此,我们描述了一种微挤压生物打印方法,用于生成由四种细胞类型组成的三维(3D)肺模型:内皮细胞、原代成纤维细胞、巨噬细胞和上皮细胞。分别选择A549和Calu-3细胞作为上皮细胞,以模拟下呼吸道和上呼吸道的细胞。细胞在由藻酸盐、明胶、透明质酸、胶原蛋白和层粘连蛋白-521组成的水凝胶中进行生物打印。这些模型在气液界面(ALI)条件下培养,以进一步增强其作为肺细胞的生理相关性。在长达21天的长期培养过程中,分析了它们的活力、代谢活性和特定细胞标志物的表达。构建体成功感染了季节性甲型流感病毒(IAV)和严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎变种,证明了它们在研究多种病毒感染方面的潜力。

相似文献

1
Bioprinted Four-Cell-Type Lung Model for Viral Infection Studies Under Air-Liquid Interface Conditions.用于气液界面条件下病毒感染研究的生物打印四细胞类型肺模型
Int J Mol Sci. 2025 Jun 10;26(12):5543. doi: 10.3390/ijms26125543.
2
The pan-variant potential of light: 425 nm light inactivates SARS-CoV-2 variants of concern and non-cytotoxic doses reduce viral titers in human airway epithelial cells.光的泛变体潜力:425纳米的光可使新冠病毒变异株失活,且非细胞毒性剂量可降低人气道上皮细胞中的病毒滴度。
mSphere. 2025 Jun 25;10(6):e0023025. doi: 10.1128/msphere.00230-25. Epub 2025 May 28.
3
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
4
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
5
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.SARS-CoV-2 中和单克隆抗体预防 COVID-19。
Cochrane Database Syst Rev. 2022 Jun 17;6(6):CD014945. doi: 10.1002/14651858.CD014945.pub2.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Application of a high-resolution melt assay for monitoring SARS-CoV-2 variants in Burkina Faso and Kenya.高分辨率熔解分析在布基纳法索和肯尼亚监测严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体中的应用。
mSphere. 2025 Jun 25;10(6):e0002725. doi: 10.1128/msphere.00027-25. Epub 2025 May 29.
8
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
9
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.
10
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.工作场所干预措施以降低医疗机构外 SARS-CoV-2 感染的风险。
Cochrane Database Syst Rev. 2022 May 6;5(5):CD015112. doi: 10.1002/14651858.CD015112.pub2.

本文引用的文献

1
Optimization of a micro-scale air-liquid-interface model of human proximal airway epithelium for moderate throughput drug screening for SARS-CoV-2.优化用于SARS-CoV-2中等通量药物筛选的人近端气道上皮微尺度气液界面模型。
Respir Res. 2025 Jan 16;26(1):18. doi: 10.1186/s12931-025-03095-y.
2
Differentiation of CD166-positive hPSC-derived lung progenitors into airway epithelial cells.将 CD166 阳性 hPSC 源性肺祖细胞分化为气道上皮细胞。
Biol Open. 2024 Jul 15;13(10). doi: 10.1242/bio.061729. Epub 2024 Oct 10.
3
3D-printed airway model as a platform for SARS-CoV-2 infection and antiviral drug testing.
3D 打印气道模型作为 SARS-CoV-2 感染和抗病毒药物测试的平台。
Biomaterials. 2024 Dec;311:122689. doi: 10.1016/j.biomaterials.2024.122689. Epub 2024 Jun 25.
4
Development of a highly stable, active small interfering RNA with broad activity against SARS-CoV viruses.开发一种高度稳定、活性高的小干扰 RNA,对 SARS-CoV 病毒具有广泛的活性。
Antiviral Res. 2024 Jun;226:105879. doi: 10.1016/j.antiviral.2024.105879. Epub 2024 Apr 9.
5
The use of human iPSC-derived alveolar organoids to explore SARS-CoV-2 variant infections and host responses.利用人诱导多能干细胞衍生的肺泡类器官探索 SARS-CoV-2 变体感染和宿主反应。
J Med Virol. 2024 Apr;96(4):e29579. doi: 10.1002/jmv.29579.
6
Xeno-Free 3D Bioprinted Liver Model for Hepatotoxicity Assessment.无动物源 3D 生物打印肝模型用于肝毒性评估。
Int J Mol Sci. 2024 Feb 2;25(3):1811. doi: 10.3390/ijms25031811.
7
A High-Throughput, High-Containment Human Primary Epithelial Airway Organ-on-Chip Platform for SARS-CoV-2 Therapeutic Screening.高通量、高封闭性人源初级气道器官芯片平台用于 SARS-CoV-2 治疗筛选。
Cells. 2023 Nov 16;12(22):2639. doi: 10.3390/cells12222639.
8
Synergistic coupling between 3D bioprinting and vascularization strategies.三维生物打印与血管化策略的协同耦合。
Biofabrication. 2023 Nov 20;16(1):012003. doi: 10.1088/1758-5090/ad0b3f.
9
Characterization of 3D-Bioprinted In Vitro Lung Cancer Models Using RNA-Sequencing Techniques.使用RNA测序技术对3D生物打印的体外肺癌模型进行表征
Bioengineering (Basel). 2023 Jun 1;10(6):667. doi: 10.3390/bioengineering10060667.
10
Lipid nanoparticle-encapsulated, chemically modified anti-adenoviral siRNAs inhibit hepatic adenovirus infection in immunosuppressed Syrian hamsters.脂质纳米颗粒包裹的化学修饰抗腺病毒小干扰RNA可抑制免疫抑制叙利亚仓鼠的肝脏腺病毒感染。
Mol Ther Nucleic Acids. 2023 May 17;32:923-936. doi: 10.1016/j.omtn.2023.05.016. eCollection 2023 Jun 13.